Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Dion's Friday ETF Winners and Losers

Stock quotes in this article: GAZ, KWT, KCE, JJC, XBI, GDXJ 

NEW YORK (TheStreet) -- Welcome to Don Dion's "ETF Winners and Losers." Be sure to stop by throughout the week to find out which ETFs are gaining or losing.

Winners

iPath Dow Jones UBS Natural Gas Subindex Total Return ETN (GAZ) 6.3%

Natural gas futures are seeing upward action following Thursday's better-than-expected-inventory report. While the premium-laden GAZ is leading, the United States Natural Gas Fund (UNG), which currently boasts no premium, is also pushing higher in early afternoon trading.

Market Vectors Solar Energy ETF (KWT) 5.8%

Other corners of the energy sector are gaining ground as well. Strength from solar names is helping to buoy not only dedicated instruments like KWT and the Guggenheim Solar ETF (TAN), but also broader alternative energy funds like the PowerShares Wilderhill Clean Energy Portfolio (PBW).

SPDR S&P Capital Markets ETF (KCE) 1.9%

KCE spent much of the past week trading sideways. However, as we head into the weekend, the fund appears to have gathered some steam and is currently retesting its 2012 highs.

Other financials-focused ETFs like the Financial Select Sector SPDR (XLF) and the SPDR S&P Regional Banking ETF (KRE) are seeing only limited upside action.

Losers

iPath Dow Jones UBS Copper Subindex Total Return ETN (JJC) -2.5%

Copper prices are stumbling as risk appetites wane heading into the long weekend.

Copper's weakness is weighing heavily on broader base metals ETFs as well. For a sixth day, the futures-backed PowerShares DB Base Metals Fund (DBB) is heading into negative territory. The fund is fast approaching its 50-day moving average. This level should be watched closely to see if it can hold up as a point of support.

SPDR S&P Biotech ETF (XBI) -1.7%

After a staggering run up during the opening weeks of the year, the biotech industry has begun to show signs of leveling off. Over the past week, funds like XBI, the First Trust Amex Biotechnology Index Fund (FBT) and the iShares NASDAQ Biotechnology Index Fund (IBB) have traded along a sideways path. It will be interesting to see which direction they choose in the days ahead.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,291.08 -3.42 -0.02%
NASDAQ 3,455.97 -3.45 -0.10%
S&P 500 1,648.69 -1.82 -0.11%
US 10 Yr 2.011% -0.012

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs